| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Morsi W Abdallah, Brad D Pearce, Nanna Larsen, Kirstin Greaves-Lord, Bent Nørgaard-Pedersen, David M Hougaard, Erik L Mortensen, Jakob Grov. Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders: an exploratory study. Autism research : official journal of the International Society for Autism Research. vol 5. issue 6. 2013-05-30. PMID:23008271. |
given the important role of matrix metalloproteinases (mmps) and neurotrophins (nts) in neuroplasticity, amniotic fluid samples for 331 asd cases and 698 frequency-matched controls were analyzed for levels of mmp-9, brain-derived neurotrophic factor, nt-4 and transforming growth factor-β utilizing a danish historic birth cohort and danish nationwide health registers. |
2013-05-30 |
2023-08-12 |
Not clear |
| Maria Spolidoro, Laura Baroncelli, Elena Putignano, José Fernando Maya-Vetencourt, Alessandro Viegi, Lamberto Maffe. Food restriction enhances visual cortex plasticity in adulthood. Nature communications. vol 2. 2011-08-25. PMID:21587237. |
these effects are accompanied by a reduction of intracortical inhibition without modulation of brain-derived neurotrophic factor expression or extracellular matrix structure. |
2011-08-25 |
2023-08-12 |
rat |
| Jonghyuck Park, Eunjeong Lim, Seungkeun Back, Heungsik Na, Yongdoo Park, Kyung Su. Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor. Journal of biomedical materials research. Part A. vol 93. issue 3. 2010-07-08. PMID:19768787. |
nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor. |
2010-07-08 |
2023-08-12 |
human |
| Kiyofumi Yamad. Endogenous modulators for drug dependence. Biological & pharmaceutical bulletin. vol 31. issue 9. 2008-10-20. PMID:18758051. |
the former including basic fibroblast growth factor, brain-derived neurotrophic factor, tissue plasminogen activator, matrix metalloproteinase (mmp)-2 and mmp-9 act to potentiate the rewarding effects of drugs, while the latter such as tumor necrosis factor-alpha and glial cell line-derived neurotrophic factor reduce the reward. |
2008-10-20 |
2023-08-12 |
Not clear |
| Ana Maria Gonzalez, Martin Berry, Lydia Greenlees, Ann Logan, Andrew Bair. Matrix-mediated gene transfer to brain cortex and dorsal root ganglion neurones by retrograde axonal transport after dorsal column lesion. The journal of gene medicine. vol 8. issue 7. 2006-09-28. PMID:16718733. |
in previous studies, we showed that the immobilisation of dnas encoding basic fibroblast growth factor, neurotrophin-3 and brain-derived neurotrophic factor in a gene-activated matrix (gam) promotes sustained survival of axotomised retinal ganglion cells after optic nerve injury. |
2006-09-28 |
2023-08-12 |
Not clear |
| R Lee, P Kermani, K K Teng, B L Hempstea. Regulation of cell survival by secreted proneurotrophins. Science (New York, N.Y.). vol 294. issue 5548. 2001-12-31. PMID:11729324. |
although proneurotrophins have been considered inactive precursors, we show here that the proforms of nerve growth factor (ngf) and the proforms of brain derived neurotrophic factor (bdnf) are secreted and cleaved extracellularly by the serine protease plasmin and by selective matrix metalloproteinases (mmps). |
2001-12-31 |
2023-08-12 |
Not clear |